ECS
ECSBOTANIC FPO [ECS]
Healthcare · ASX Small Cap
$0.0050 +0.0%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical51
Catalyst51
Sentiment50
Fundamental42
Momentum51
Risk Gate27
Get alerts when ECS's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Stochastic just turned bullish from a low level — early reversal sign
- Volume surging at 9.1x normal while price falls — heavy selling pressure
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Critical cash runway (1.5 quarters)
- Low P/S ratio (0.4x)
- Moderate revenue growth (+16%)
- Near 52-week low (5% of range)
- Micro-cap ($5-20M) - high risk
- CANSLIM A: Turned profitable
- Sentiment is mixed — no strong consensus either way
- The bigger volume days are the up days — volume-weighted momentum is positive (2.95%/day)
- Altman Z-Score distress zone (1.20 < 1.81, low-confidence approx)
- Penny stock risk ($0.005)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (2/9, low-confidence approx)
- Deeply negative margins (-22%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 40% over the past year
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about ECS
3 free messages/day · Unlimited with Pro
Recent Catalysts
LOW ECS to Present at NWR Healthcare Conference - Thu 26 Mar
NONE HY FY26 Results Presentation
NONE Notification of cessation of securities - ECS
NONE H1 FY26 Results-Return to Profitability & Positive Cashflow
Recent ASX Announcements
| 2026-03-18 | ECS to Present at NWR Healthcare Conference - Thu 26 Mar |
| 2026-03-03 | HY FY26 Results Presentation |
| 2026-03-03 | Notification of cessation of securities - ECS |
| 2026-02-27 | H1 FY26 Results-Return to Profitability & Positive Cashflow PRICE SENSITIVE |
| 2026-02-27 | Half Yearly Report and Accounts PRICE SENSITIVE |
Key Metrics
$8.0M
Market Cap
1.2M
Avg Volume
9.1x
Vol Ratio
$0.00 — $0.01
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-18.3%
ROE
-21.9%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | improving | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 62% |
| L | Leader vs Laggard | laggard | RS: -4 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #73 of 117 · Sector avg: 46
View all Healthcare signals →Track ECS and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required